Cambridge Investment Research Advisors’s Travelers Companies TRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.81M Buy
26,678
+233
+0.9% +$70.6K 0.02% 708
2026
Q1
$7.71M Sell
26,445
-103
-0.4% -$30.2K 0.02% 728
2025
Q4
$7.7M Buy
26,548
+770
+3% +$217K 0.02% 705
2025
Q3
$7.2M Buy
25,778
+674
+3% +$180K 0.02% 719
2025
Q2
$6.72M Sell
25,104
-1,621
-6% -$427K 0.02% 706
2025
Q1
$7.07M Buy
26,725
+2,680
+11% +$668K 0.02% 640
2024
Q4
$5.79M Sell
24,045
-446
-2% -$111K 0.02% 720
2024
Q3
$5.73M Sell
24,491
-1,665
-6% -$367K 0.02% 734
2024
Q2
$5.32M Buy
26,156
+1,867
+8% +$401K 0.02% 724
2024
Q1
$5.59M Sell
24,289
-2,637
-10% -$563K 0.02% 692
2023
Q4
$5.13M Buy
26,926
+836
+3% +$145K 0.02% 689
2023
Q3
$4.26M Sell
26,090
-1,155
-4% -$193K 0.02% 730
2023
Q2
$4.73M Sell
27,245
-15
-0.1% -$2.65K 0.02% 688
2023
Q1
$4.67M Buy
27,260
+1,096
+4% +$199K 0.02% 664
2022
Q4
$4.91M Buy
26,164
+2,670
+11% +$480K 0.03% 615
2022
Q3
$3.6M Sell
23,494
-1,147
-5% -$186K 0.02% 718
2022
Q2
$4.17M Buy
24,641
+225
+0.9% +$39.1K 0.02% 665
2022
Q1
$4.46M Sell
24,416
-589
-2% -$101K 0.02% 684
2021
Q4
$3.91M Buy
25,005
+810
+3% +$127K 0.02% 770
2021
Q3
$3.68M Buy
24,195
+396
+2% +$61.3K 0.02% 756
2021
Q2
$3.56M Sell
23,799
-1,124
-5% -$174K 0.02% 789
2021
Q1
$3.75M Buy
24,923
+399
+2% +$58.6K 0.02% 691
2020
Q4
$3.44M Sell
24,524
-1,050
-4% -$135K 0.02% 657
2020
Q3
$2.77M Sell
25,574
-31,937
-56% -$3.66M 0.02% 652
2020
Q2
$6.56M Buy
57,511
+3,035
+6% +$320K 0.05% 354
2020
Q1
$5.41M Buy
54,476
+27,055
+99% +$3.36M 0.05% 344
2019
Q4
$3.75M Buy
27,421
+660
+2% +$89.8K 0.03% 572
2019
Q3
$3.98M Buy
26,761
+643
+2% +$95.6K 0.03% 508
2019
Q2
$3.9M Buy
26,118
+219
+0.8% +$31.6K 0.04% 485
2019
Q1
$3.55M Sell
25,899
-28,257
-52% -$3.62M 0.03% 494
2018
Q4
$6.49M Buy
54,156
+1,654
+3% +$207K 0.07% 256
2018
Q3
$6.81M Buy
52,502
+736
+1% +$95K 0.07% 290
2018
Q2
$6.33M Sell
51,766
-1,173
-2% -$154K 0.07% 272
2018
Q1
$7.35M Buy
52,939
+2,763
+6% +$386K 0.08% 239
2017
Q4
$6.81M Buy
50,176
+2,816
+6% +$372K 0.08% 246
2017
Q3
$5.8M Buy
47,360
+3,938
+9% +$492K 0.08% 246
2017
Q2
$5.49M Buy
+43,422
New +$5.34M 0.08% 240
2016
Q4
Sell
-29,968
Closed -$3.43M 1811
2016
Q3
$3.43M Buy
+29,968
New +$3.51M 0.06% 287
2016
Q2
Sell
-19,336
Closed -$2.26M 1675
2016
Q1
$2.26M Buy
19,336
+265
+1% +$28.9K 0.05% 326
2015
Q4
$2.15M Buy
+19,071
New +$2.12M 0.05% 339
2015
Q3
Sell
-16,197
Closed -$1.57M 1580
2015
Q2
$1.57M Sell
16,197
-5,449
-25% -$558K 0.04% 369
2015
Q1
$2.34M Buy
21,646
+603
+3% +$64.4K 0.07% 277
2014
Q4
$2.23M Buy
21,043
+495
+2% +$50K 0.07% 271
2014
Q3
$1.93M Sell
20,548
-107
-0.5% -$9.98K 0.06% 328
2014
Q2
$1.94M Sell
20,655
-899
-4% -$82K 0.07% 280
2014
Q1
$1.83M Buy
21,554
+4,713
+28% +$396K 0.07% 279
2013
Q4
$1.52M Buy
16,841
+503
+3% +$44K 0.06% 303
2013
Q3
$1.39M Buy
16,338
+1,752
+12% +$145K 0.06% 287
2013
Q2
$1.17M Buy
+14,586
New +$1.23M 0.06% 288

Other funds holding TRV

Cambridge Investment Research Advisors's TRV Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Travelers Companies (TRV) stake by 0.88% in Q2 2026, buying an estimated $70.6K and bringing the position to 26,678 shares worth $8.81M. The position accounts for 0.02% of the portfolio, ranked #708.

Cambridge Investment Research Advisors first reported a position in TRV in Q2 2013 and has held it in 49 quarters since. 632 funds tracked by Wall St. Rank hold TRV as of Q2 2026.

  • Cambridge Investment Research Advisors held 26,678 shares of Travelers Companies worth $8.81M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 233 Travelers Companies shares in Q2 2026, an estimated $70.6K.
  • Travelers Companies made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #708 holding.
  • Cambridge Investment Research Advisors first reported a position in Travelers Companies in Q2 2013 and has held it in 49 quarters since.
  • 632 funds tracked by Wall St. Rank held Travelers Companies as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.